Concordia International Corp. (formerly Concordia Healthcare Corp.)
|
|||
| Mailing Address: | 277 Lakeshore Rd. East Suite 302 Oakville, Ontario L6J 1H9 |
Head Office Address: | 277 Lakeshore Rd. East Suite 302 Oakville, Ontario L6J 1H9 |
| Contact Name: | Francesco Tallarico | Principal Regulator: | Ontario |
| Business e-mail address: | Francesco.tallarico@concordiarx.com | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 905 842-5150 | Reporting Jurisdictions: | British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland |
| Fax Number: | 905 842-5154 | Stock Exchange: | TSX, NASDAQ |
| Date of Formation: | Jan 20 2010 | Stock Symbol: | CXR |
| Jurisdiction Where Formed: | Ontario | Auditor: | PricewaterhouseCoopers LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 20653P | Transfer Agent: | TSX Trust Company |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | Over $1,000,000,000 |
|
